Evolent Health (EVH) Tops Q2 EPS by 5c, Rases Guidance
Get Alerts EVH Hot Sheet
Join SI Premium – FREE
Evolent Health (NYSE: EVH) reported Q2 EPS of $0.10, $0.05 better than the analyst estimate of $0.05. Revenue for the quarter came in at $319.9 million versus the consensus estimate of $298.79 million.
GUIDANCE:
Evolent Health sees FY2022 revenue of $1.32-1.36 billion, versus the consensus of $1.22 billion.
Evolent Health sees Q3 2022 revenue of $343-363 million, versus the consensus of $312.7 million.
For earnings history and earnings-related data on Evolent Health (EVH) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- urban-gro Inc. (UGRO) Misses Q4 EPS by 22c, offers outlook
- MillerKnoll, Inc. (MLKN) Tops Q3 EPS by 1c; offers Q4 guidance
- Schwazze (SHWZ) Misses Q4 EPS by 30c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!